Besides, Zhang et al. elucidated that EGCG in 400 mg capsules orally administered three times per day to breast cancer patients undergoing radiotherapy resulted in significantly lower serum levels of VEGF, HGF, MMP9 and MMP2, when compare to patients who received radiotherapy alone [36]. Here, MMP9 is linked to breast carcinoma.